Canadian Pharmaceutical Company Probes Supplier for Possible ‘Improper Payments’
The company has contacted U.S. and Canadian authorities over potential foreign bribery.
This story is exclusively for members of the
JUST ANTI-CORRUPTION COMMUNITY
Subscribe







